Testing effectiveness (Phase 2)WithdrawnNCT02569125
What this trial is testing
Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome
Who this might be right for
Segmental Overgrowth Syndrome
Jochen Roessler
Showing 2 of 2 results